The 11th Circuit decision in Schering-Plough Corp. v. Federal Trade Commission, 402 F.3d 1056 (11th Cir. 2005), continues the progression of judicial examination inherent in the conflict between patent law and antitrust law under the Hatch-Waxman Act — an issue that the Supreme Court may ultimately decide.
The 11th Circuit vacated a decision of the Federal Trade Commission, finding that royalty payments flowing from a patent holder to two authorized generics, constituted an unreasonable restraint of trade in violation of �1 of the Sherman Antitrust Act, 15 U.S.C. �1 and �5 of the Federal Trade Commission Act, 15 U.S.C. �45(a).
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]